Chiesi UK and Ireland has announced a new programme to help transform COPD diagnosis across the UK by providing NHS primary ...

The results for litifilimab support the potential to achieve rapid and durable improvements in skin disease activity ...

The annual awards recognise excellence across 15 categories spanning innovation, manufacturing, sustainability and leadership ...

People living with rare diseases are being offered two years’ free access to an AI-powered app that captures medical ...

In a recent interview with Pharma Exec, Elaine Ferguson, Global President of Inizio Medical, explores how pharma leadership ...

This builds on a recently announced clinical collaboration between AstraZeneca and Summit to advance cancer treatments ...

Explore how pharma can help patients and patient organisations prepare for meaningful involvement in EU HTA without shaping ...

MSD, known as Merck in the US and Canada, has announced the first presentation of results from MK-7240-012, a phase 2b ...

Treatment with Olumiant resulted in substantial scalp hair regrowth, as well as improvements in eyebrows and eyelashes ...

GSK has signed a new three-year agreement with Protas that aims to streamline trials across several core therapeutic areas. Protas will provide a variety of scientifically led and operational ...

Merck (known as MDS outside the US and Canada) has announced that Ogsiveo (nirogacestat) has been recommended by the National ...

As a cross-functional leader with experience managing pricing and access strategy across more than 60 markets, she is the ...